06-4499. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Implementation of Human Papillomavirus Vaccination in Communities With Elevated Rates of Cervical Cancer, Potential Extramural Project (PEP) 2006-R-02

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Implementation of Human Papillomavirus Vaccination in Communities with Elevated Rates of Cervical Cancer, Potential Extramural Project (PEP) 2006-R-02.

Time and Date: 12 a.m.-5 p.m., May 25, 2006 (Closed).

Place: Centers for Disease Control and Prevention, Building 21, Conference Room 8116, 8th Floor, 1600 Clifton Road, Atlanta, GA 30333, Telephone [phone].

Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to “The Implementation of Human Papillomavirus Vaccination in Communities with Elevated Rates of Cervical Cancer,” PEP 2006-R-02.

Due to programmatic matters, this Federal Register Notice is being published on less than 15 calendar days notice to the public (41 CFR 102-3.150(b)).

For Further Information Contact: Jim Newhall, PhD., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS D-72, Atlanta, GA 30333, Telephone [phone].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 8, 2006.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.